Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06322615 · ClinicalTrials.gov registry record · NA
Acupressure for Reducing Anxiety in Patients Undergoing Chemotherapy
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT06322615: Completed NA study, sponsored by Mayo Clinic.
NCT06322615 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06322615, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This clinical trial evaluates whether acupressure is helpful to reduce anxiety related to chemotherapy. Anxiety is experienced by many patients with cancer. Anxiety can be related to chemotherapy and may contribute to other symptoms, such as nausea and poor quality of life. Some patients diagnosed with cancer express interest in non-medicinal ways to manage symptoms. Acupressure is a noninvasive intervention that can be used for many different symptoms. Acupressure is well tolerated with minimal reports of adverse reactions, making it a good choice for patients with cancer. This study may help researchers learn whether acupressure is useful for managing anxiety in patients undergoing chemotherapy.
Interventions
- OTHER Questionnaire Administration
- OTHER Educational Intervention
- OTHER Electronic Health Record Review
- PROCEDURE Acupressure Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-08-08 |
| Est. Completion | 2024-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06322615
The ClinicalTrials.gov registry entry for NCT06322615 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT06322615 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06322615 about?
NCT06322615 is a clinical study titled "Acupressure for Reducing Anxiety in Patients Undergoing Chemotherapy". This clinical trial evaluates whether acupressure is helpful to reduce anxiety related to chemotherapy. Anxiety is experienced by many patients with cancer. Anxiety can be related to chemotherapy and may contribute to other symptoms, such as nausea and poor quality of life. Some patients diagnosed w...
What is the current status of trial NCT06322615?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-08-08. Estimated completion is 2024-02-01.
What interventions are being tested in trial NCT06322615?
The interventions under investigation include: Questionnaire Administration (OTHER), Educational Intervention (OTHER), Electronic Health Record Review (OTHER), Acupressure Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT06322615?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.